ZOETIS INC. (ZTS) News
Latest headlines that mention ZTS, newest first · each headline opens the original publisher
- Last price
- $79.89
- Day change
- -2.71%
- Next earnings
- —
ZTS headlines
last 30 daysFast lifecycle approvals, such as Simparica Duo, are how Zoetis plans to extend its core franchises beyond today's pressured pet care market.
Competitive pressure eased in dermatology, but clinic visits softened
Zoetis stock reversed lower at the open Thursday after the pet health giant reported "generally fine" third-quarter metrics, an analyst said. The post No Greyhounds Here: Pet-Health Giant Zoetis Reverses 30% Monthlong Sprint appeared first on Investor's Business Daily .
ZTS news alerts
Get an alert by email or push when a new headline mentions ZTS.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.